DAKIN'S SOLUTION 0.5% MODIFIED 5 G — DIN 00658529
SODIUM HYPOCHLORITE : 5 G · CENTURY PHARMACEUTICALS INC. · SOLUTION · wholesale supply in Canada
Health Canada status: DORMANT
What is DAKIN'S SOLUTION 0.5% MODIFIED?
DAKIN'S SOLUTION 0.5% MODIFIED 5 G contains SODIUM HYPOCHLORITE : 5 G. It is listed in the Health Canada Drug Product Database under DIN 00658529, held by CENTURY PHARMACEUTICALS INC., supplied as SOLUTION for TOPICAL administration. Health Canada currently lists it as dormant, status dated 30-Jul-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
Is there a generic Sodium Hypochlorite in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
2 holders have a Canadian DIN containing Sodium Hypochlorite, across 3 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ALCAVIS HDC LLC | 2 | 0 | EXSEPT, EXSEPT (0.114%) | No marketed DIN |
| CENTURY PHARMACEUTICALS INC. | 1 | 0 | DAKIN'S SOLUTION 0.5% MODIFIED | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 5 G |
|---|---|
| Dosage form | SOLUTION |
| Route | TOPICAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Sodium Hypochlorite |
|---|---|
| ATC code | D08AX07 |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00658529 |
|---|---|
| DIN (unpadded, as printed on some documents) | 658529 |
| Brand name | DAKIN'S SOLUTION 0.5% MODIFIED |
| Generic / active ingredient | SODIUM HYPOCHLORITE : 5 G |
| Market authorization holder | CENTURY PHARMACEUTICALS INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D08AX07 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D08AX |
| Current status | DORMANT |
| Status date | 30-Jul-2018 |
| Original market date | 1985-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Sodium Hypochlorite in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 3 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| EXSEPT | 0.057 % | LIQUID | ALCAVIS HDC LLC | CANCELLED POST MARKET | 02245530 |
| EXSEPT (0.114%) | 0.114 % | LIQUID | ALCAVIS HDC LLC | CANCELLED POST MARKET | 02245790 |
2 · Same class — other molecules in ATC D08AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ethanol | ALCO-GEL - TOP 60% · ARNICA HAND SANITIZER GENTLE ANTI-BACTERIAL GEL · AVON SKIN SO SOFT ANTIBACTERIAL MOISTURIZING HAND GEL · AVON SKIN SO SOFT ANTIBACTERIAL MOISTURIZING HAND GEL WITH ALCOHOL 60% · +41 more | 46 | 0 | Not in Canada |
| Isopropanol | ALCOGEL · ALCOHOL PREP F400 70% LIQ · ALCOHOL RUB · ALCOJEL · +30 more | 42 | 0 | Not in Canada |
| Other Antiseptics And Disinfectants | ALCORUB (RUBBING ALCOHOL COMPOUND) · AVON CLEARSKIN ANTIBACTERIAL CLEANSING CAKE · BENZOINSPRAY - AER 25% · CLEARASIL DAILY FACE WASH LOT 2% · +18 more | 22 | 0 | Not in Canada |
| Hydrogen Peroxide | HIOXYL CREAM · HYDROGEN PEROXIDE 20VOL · HYDROGEN PEROXIDE 6% · HYDROGEN PEROXIDE LIQ 10VOL · +7 more | 12 | 0 | Not in Canada |
| Ethanol, Combinations | ACTIPREP · COMPOUND BENZOIN TINCTURE · COMPOUND BENZOIN TINCTURE USP · MANORAPID SYNERGY · +2 more | 6 | 0 | Not in Canada |
| Isopropanol, Combinations | DURAPREP SURGICAL SOLUTION · ONE TIME PREP SWAB F423 · ONE TIME SWAB STICKS F464 | 3 | 0 | Not in Canada |
| Sodium Hypochlorite | DAKIN'S SOLUTION 0.5% MODIFIED · EXSEPT · EXSEPT (0.114%) | 3 | 0 | Not in Canada |
| Tosylchloramide Sodium | CHLORAZENE WHIRLPOOL ANTISEPTIC PWR | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D08A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D08AJ | Benzalkonium · Benzalkonium, Combinations · Benzethonium Chloride · Benzethonium Chloride, Combinations · Cetrimide · +2 more | 385 | 42 |
| D08AC | Chlorhexidine · Chlorhexidine, Combinations · Hexamidine | 143 | 33 |
| D08AE | Chloroxylenol · Chloroxylenol, Combinations · Combinations, Of Phenol And Derivatives · Hexachlorophene · Metacresolsulphonic Acid-Formaldehyde · +2 more | 458 | 16 |
| D08AB | Aluminium Agents | 7 | 0 |
| D08AG | Iodine · Iodine Products · Iodine, Combinations · Povidone-Iodine · Povidone-Iodine, Combinations | 50 | 0 |
| D08AH | Clioquinol | 2 | 0 |
| D08AD | Boric Acid Products | 7 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.